Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth

International Journal of Cancer

Volumn 135, Issue 3, 2014, Pages 551-562

  Depner, Sofia ^a   Lederle, Wiltrud ^b   Gutschalk, Claudia ^a   Linde, Nina ^a   Zajonz, Alexandra ^a   Mueller, Margareta M ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c FURTWANGEN UNIVERSITY   (Germany)

Author keywords

Fibroblasts; Growth factor network; Interleukin 6; MMP; SCC; Tumor progression

Indexed keywords

GELATINASE A; INTERLEUKIN 6; MATRIX METALLOPROTEINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 1; SCATTER FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL SPECIFICITY; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN CARCINOGENESIS; SKIN CARCINOMA; STROMA CELL; TUMOR INVASION;

FIBROBLASTS; GROWTH FACTOR NETWORK; INTERLEUKIN-6; MMP; SCC; TUMOR PROGRESSION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FIBROBLASTS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IN SITU HYBRIDIZATION; INTERLEUKIN-6; KERATINOCYTES; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; SKIN NEOPLASMS; STROMAL CELLS;

EID: 84901046779     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27951     Document Type: Article

References (48)

1. Fischer P, Lehmann U, Sobota RM, et al. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochem J 2004; 378: 449-460.
2. Corcoran NM, Costello AJ,. Interleukin-6: minor player or starring role in the development of hormone-refractory prostate cancer? BJU Int 2003; 91: 545-553.
3. Trikha M, Corringham R, Klein B, et al. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 2003; 9: 4653-4665.
4. Keller ET, Wanagat J, Ershler WB,. Molecular and cellular biology of interleukin-6 and its receptor. Front Biosci 1996; 1: d340-d357.
5. Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003; 88: 1721-1726.
6. Lederle W, Depner S, Schnur S, et al. IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int J Cancer 2011; 128: 2803-2814.
7. Mueller MM, Fusenig NE,. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-849.
8. Zeisberg M, Strutz F, Muller GA,. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 2000; 13 (Suppl 3): S111-S120.
9. Chang GC, Liu R, Panniers R, Li GC,. Rat fibroblasts transfected with the human 70-kDa heat shock gene exhibit altered translation and eukaryotic initiation factor 2 alpha phosphorylation following heat shock. Int J Hypertherm 1994; 10: 325-337.
10. Kurose K, Hoshaw-Woodard S, Adeyinka A, et al. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001; 10: 1907-1913.
11. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348.
12. Olumi AF, Grossfeld GD, Hayward SW, et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-5011.
13. Atula S, Grenman R, Syrjanen S,. Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro. Exp Cell Res 1997; 235: 180-187.
14. Tlsty TD, Hein PW,. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11: 54-59.
15. Le NT, Xue M, Castelnoble LA, et al. The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 2007; 12: 1475-1487.
16. Lederle W, Stark HJ, Skobe M, et al. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol 2006; 169: 1767-1783.
17. Stacey A, Doyle A,. Routine testing of cell cultures and their products for mycoplasma contamination. Methods Mol Biol 1997; 75: 305-311.
18. Lederle W, Linde N, Heusel J, et al. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas. Am J Pathol 2010; 176: 981-994.
19. Lederle W, Hartenstein B, Meides A, et al. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma. Carcinogenesis 2010; 31: 1175-1184.
20. Vosseler S, Lederle W, Airola K, et al. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion. Int J Cancer 2009; 125: 2296-2306.
21. Szabowski A, Maas-Szabowski N, Andrecht S, et al. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 2000; 103: 745-755.
22. Xiao W, Hodge DR, Wang L, et al. NF-kappaB activates IL-6 expression through cooperation with c-Jun and IL6-AP1 site, but is independent of its IL6-NFkappaB regulatory site in autocrine human multiple myeloma cells. Cancer Biol Therapy 2004; 3: 1007-1017.
23. Shariat SF, Chromecki TF, Hoefer J, et al. Soluble gp130 regulates prostate cancer invasion and progression in an interleukin-6 dependent and independent manner. J Urol 2011; 186: 2107-2114.
24. Conti I, Rollins BJ,. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004; 14: 149-154.
25. Brown CE, Vishwanath RP, Aguilar B, et al. Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells. J Immunol 2007; 179: 3332-3341.
26. Mishra P, Banerjee D, Ben-Baruch A,. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 2011; 89: 31-39.
27. Sporri B, Muller KM, Wiesmann U, et al. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts. Int Immunol 1999; 11: 1053-1058.
28. Nakamura T, Matsumoto K, Kiritoshi A, et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 1997; 57: 3305-3313.
29. Cohen M, Marchand-Adam S, Lecon-Malas V, et al. HGF synthesis in human lung fibroblasts is regulated by oncostatin M. American journal of physiology. Lung Cell Mol Physiol 2006; 290: L1097-L1103.
30. Liu Y, Michalopoulos GK, Zarnegar R,. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 1994; 269: 4152-4160.
31. Skibinski G, Elborn JS, Ennis M,. Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor. Am J Physiol. Lung cellular and molecular physiology 2007; 293: L69-L76.
32. Rasanen K, Salmenpera P, Baumann M, et al. Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells. Mol Oncol 2008; 2: 340-348.
33. Silzle T, Randolph GJ, Kreutz M, et al. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004; 108: 173-180.
34. Pietras K, Ostman A,. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010; 316: 1324-1331.
35. Xing F, Saidou J, Watabe K,. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 2010; 15: 166-179.
36. Rattigan YI, Patel BB, Ackerstaff E, et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 2012; 318: 326-335.
37. Angeli F, Koumakis G, Chen MC, et al. Role of stromal fibroblasts in cancer: promoting or impeding? Tumour Biol 2009; 30: 109-120.
38. Xing F, Saidou J, Watabe K,. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 2010; 15: 166-179.
39. Bjornland K, Flatmark K, Pettersen S, et al. Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 2005; 127: 151-156.
40. Olsen CJ, Moreira J, Lukanidin EM, Ambartsumian NS,. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts. BMC Cancer 2010; 10: 444.
41. Saad S, Gottlieb DJ, Bradstock KF, et al. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002; 62: 283-289.
42. Obermueller E, Vosseler S, Fusenig NE, et al. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 2004; 64: 7801-7812.
43. Woenne EC, Lederle W, Zwick S, et al. MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression. Anticancer Res 2010; 30: 703-711.
44. Fujiuchi Y, Nagakawa O, Murakami K, et al. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol Rep 2003; 10: 1001-1006.
45. Esposito C, Parrilla B, Cornacchia F, et al. The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth. Growth Factors 2009; 27: 173-180.
46. Hirata M, Sato T, Tsumagari M, et al. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biol Reprod 2003; 68: 1276-1281.
47. Klier CM, Nelson PJ,. Chemokine-induced extravasation of MonoMac 6 cells: chemotaxis and MMP activity. Ann N Y Acad Sci 1999; 878: 575-577.
48. Werle M, Schmal U, Hanna K, et al. MCP-1 induces activation of MAP-kinases ERK, JNK and p38 MAPK in human endothelial cells. Cardiovasc Res 2002; 56: 284-292.